Skip to main content
Toggle navigation
About Us
What We Do
Who We Work With
Our Leadership Team
How Can We Help?
Our Services
Sponsorship
Costings & Contracts
Study Management & Support
Delivery Team
Primary Care & Non-NHS
Training & Events
Glossary
News
Contact Us
Register
Log in
Search form
Search
Research Glossary
test
Research Glossary
A
B
C
D
E
F
G
H
I
J
L
M
N
O
P
Q
R
S
T
U
V
W
A
Adverse Event
Adverse Reaction
Amendments
Archive
Audit
B
Baseline
Blinding
C
Case Report Form (CRF)
Chief Investigator
Clinical Trial Authorisation (CTA)
Clinical Trial Investigation of Medicinal Product (CTIMP)
D
Delegation Log
Development Safety Update Report (DSUR)
E
Early Termination
Eligibility Criteria
End of Study
F
Follow-Up
G
Good Clinical Practice
H
Health Research Authority (HRA)
HRA Approval
Human Tissue Samples
I
Independent Data Monitoring Committee
Informed Consent
Inspection
Investigator Site File
IRAS
J
Journal
L
Lay Summary
Letter of Access
Likert Scale
M
Medicines and Healthcare products Regulatory Agency (MHRA)
Monitoring
N
National Institute of Health Research (NIHR)
NIHR Portfolio Studies
Non-NHS Sites
O
Observational Data
1
2
next ›
last »
